These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 12056292)
21. Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: a Department of Veterans Affairs cooperative study. Clegg DO; Reda DJ; Abdellatif M Arthritis Rheum; 1999 Nov; 42(11):2325-9. PubMed ID: 10555027 [TBL] [Abstract][Full Text] [Related]
22. Predictors of Clinical Remission under Anti-tumor Necrosis Factor Treatment in Patients with Ankylosing Spondylitis: Pooled Analysis from Large Randomized Clinical Trials. Baraliakos X; Koenig AS; Jones H; Szumski A; Collier D; Bananis E J Rheumatol; 2015 Aug; 42(8):1418-26. PubMed ID: 26077401 [TBL] [Abstract][Full Text] [Related]
23. Is sulfasalazine effective in ankylosing spondylitis? A systematic review of randomized controlled trials. Chen J; Liu C J Rheumatol; 2006 Apr; 33(4):722-31. PubMed ID: 16583475 [TBL] [Abstract][Full Text] [Related]
24. [Basic therapeutics in the management of various forms of arthritis]. Sieper J Orthopade; 1998 Aug; 27(8):576-80. PubMed ID: 9779434 [No Abstract] [Full Text] [Related]
25. Sulphasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients. Dougados M; Boumier P; Amor B Br Med J (Clin Res Ed); 1986 Oct; 293(6552):911-4. PubMed ID: 2876744 [TBL] [Abstract][Full Text] [Related]
26. Critical appraisal of the guidelines for the management of ankylosing spondylitis: disease-modifying antirheumatic drugs. Soriano ER; Clegg DO; Lisse JR Am J Med Sci; 2012 May; 343(5):357-9. PubMed ID: 22543537 [TBL] [Abstract][Full Text] [Related]
27. Conventional DMARDs in axial spondyloarthritis: wishful--rather than rational--thinking! Landewé RB Ann Rheum Dis; 2015 Jun; 74(6):951-3. PubMed ID: 25795908 [No Abstract] [Full Text] [Related]
28. Female patients with ankylosing spondylitis: analysis of the impact of gender across treatment studies. van der Horst-Bruinsma IE; Zack DJ; Szumski A; Koenig AS Ann Rheum Dis; 2013 Jul; 72(7):1221-4. PubMed ID: 23264358 [TBL] [Abstract][Full Text] [Related]
29. Are there any antirheumatic drugs that modify the course of ankylosing spondylitis? Laurent R Baillieres Clin Rheumatol; 1990 Aug; 4(2):387-400. PubMed ID: 1674450 [No Abstract] [Full Text] [Related]
30. Meta-analysis of sulfasalazine in ankylosing spondylitis. Ferraz MB; Tugwell P; Goldsmith CH; Atra E J Rheumatol; 1990 Nov; 17(11):1482-6. PubMed ID: 1980310 [TBL] [Abstract][Full Text] [Related]
32. Conventional DMARD therapy (methotrexate-sulphasalazine) may decrease the requirement of biologics in routine practice of ankylosing spondylitis patients: a real-life experience. Can M; Aydın SZ; Niğdelioğlu A; Atagündüz P; Direskeneli H Int J Rheum Dis; 2012 Dec; 15(6):526-30. PubMed ID: 23253235 [TBL] [Abstract][Full Text] [Related]